Wall Street Zen Upgrades EUDA Health (NASDAQ:EUDA) to “Hold”

EUDA Health (NASDAQ:EUDA) was upgraded by stock analysts at Wall Street Zen to a “hold” rating in a report released on Saturday, Wall Street Zen reports.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of EUDA Health in a report on Wednesday, August 5th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $55.00.

EUDA Health Price Performance

NASDAQ:EUDA opened at $15.40 on Friday. The company has a 50-day moving average price of $15.45 and a 200-day moving average price of $14.31. EUDA Health has a 12 month low of $5.26 and a 12 month high of $71.80. The company has a quick ratio of 2.53, a current ratio of 2.53 and a debt-to-equity ratio of 0.01.

EUDA Health (NASDAQ:EUDA) last announced its earnings results on Tuesday, September 29th. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.57). The firm had revenue of $1.73 million for the quarter, compared to analysts’ expectations of $9.61 million.

EUDA Health Company Profile

EUDA Health Holdings Limited is a healthcare technology company focused on providing digital and technology-enabled healthcare services. Through its platform and affiliated healthcare operations, the company aims to connect patients with medical professionals and make healthcare services more accessible through digital channels.

Its activities include telehealth and online medical consultations, healthcare information and patient-management services, and related wellness and medical support offerings.